10 Stocks That Will Change the World

Page 6 of 13

8. Beam Therapeutics Inc. (NASDAQ:BEAM)

Number of Hedge Fund Holders In Q1 2024: 23

Beam Therapeutics Inc. (NASDAQ:BEAM) is a biotechnology company that develops treatments for thalassemia, sickle cell disease, and other ailments. It is one of the most consequential biotechnology stocks as of late, as evidenced by its gene editing platform that works along with industry leading CRISPR slicing. This has allowed Beam Therapeutics Inc. (NASDAQ:BEAM) to target genetic diseases, which have long been thought of as having no cure. This leaves a wide market open for exploitation, and Beam Therapeutics Inc. (NASDAQ:BEAM) is already dosing patients for its historic attempt at helping those who suffer from sickle cell disease. On the flip side, the risks are equally higher, as any negatives on the regulatory or safety front could bode into disaster for the firm. Beam Therapeutics Inc. (NASDAQ:BEAM) also has hefty cash reserves of $1.1 billion which should help it try to crack the nut of genetic diseases for quite some time.

Page 6 of 13